fludarabine and Anemia, Hemolytic, Autoimmune

fludarabine has been researched along with Anemia, Hemolytic, Autoimmune in 48 studies

Research

Studies (48)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	22 (45.83)	18.2507
2000's	16 (33.33)	29.6817
2010's	9 (18.75)	24.3611
2020's	1 (2.08)	2.80

Authors

Authors	Studies
Barcellini, W; Berentsen, S; Brudevold, R; D'Sa, S; Dahm, AEA; Dalgaard, J; Fattizzo, B; Frøen, H; Hallstensen, RF; Haukås, E; Hjorth-Hansen, H; Jæger, PH; Kell, M; Małecka, A; Oksman, M; Randen, U; Rolke, J; Sekhar, M; Sørbø, JH; Tjønnfjord, E; Tjønnfjord, GE; Tsykunova, G; Tvedt, THA	1
Go, RS; Kay, NE; Winters, JL	1
Chauffaille, MLLF; Fonseca, ARBMD; Goncalves, MV; Guedes, NR; Lacerda, MP; Pereira, AD; Rodrigues, CA; Yamakawa, PE; Yamamoto, M	1
Banov, L; Calvillo, M; Dufour, C; Fioredda, F; Fischer, A; Gallicola, F; Miano, M; Micalizzi, C; Molinari, AC; Montobbio, G; Parasole, R; Petruzziello, F; Poggi, V; Svahn, J	1
Beum, PV; Lee, E; Lindorfer, MA; Marti, G; Mo, CC; Njuguna, N; Taylor, RP; Vire, B; Wiestner, A; Wilson, WH	1
Hoffman, PC	1
Beiske, K; Berentsen, S; Dalgaard, J; Hjorth-Hansen, H; Jacobsen, EM; Randen, U; Thoresen, AS; Tjønnfjord, GE; Vågan, AM; Vik, A	1
Berentsen, S	1
Andersohn, F; Bronder, E; Garbe, E; Grüneisen, A; Hildebrandt, M; Klimpel, A; Kurtal, H; Mayer, B; Salama, A; Schrezenmeier, H; Späth-Schwalbe, E; Thomae, M	1
Bhattacharyya, J; Kimura, A; Mihara, K; Takihara, Y	1
Berentsen, S; Tjønnfjord, GE	1
Paydas, S	1
Asch, J; Ford, CD; Petersen, FB; Pulsipher, M	1
Fay, M; Murphy, PT; Nolan, A; O'Donnell, R; Quinn, J; Swords, R	1
Khurshid, M; Syed, NN	1
Alberto, MF; Fernández-Calotti, P; Gamberale, R; Geffner, J; Giordano, M; Sánchez-Avalos, J	1
Ikeda, Y; Murase, T; Nishida, H; Park, JW; Ueno, H; Yano, T	1
Smolej, L	1
Cutting, R; Edbrooke, D; El-Ghariani, K; Ezaydi, Y; Snowden, JA; Stamps, R	1
Celsing, F; Hansson, L; Karlsson, C; Lundin, J	1
Borthakur, G; Cortes, JE; Giles, FJ; Kantarjian, HM; Keating, MJ; Lerner, S; O'Brien, S; Thomas, DA; Wierda, WG	1
Cascavilla, N; D'Arena, G	1
Garratty, G; Petz, LD	1
del Villar, V; López, L; Pascual, T	1
Leoni, P; Montillo, M; Tedeschi, A	1
Cacciola, E; Di Raimondo, F; Giustolisi, R; Kantarjian, H; Keating, MJ; O'Brien, S; Robertson, LB	1
Copplestone, JA; Craig, V; Curtis, D; Hamblin, TJ; Hamon, MD; Myint, H; Orchard, J; Oscier, DG; Prentice, AG	1
Maclean, R; Meiklejohn, D; Soutar, R	1
Saven, A	1
Crozat-Grosleron, S; Dubois, A; Reynaud, D; Rossi, JF; Yeche, S	1
Bayle, C; Cartron, J; Lambert, T; Rudent, A; Tchernia, G; Tertian, G	1
Jacobs, A	1
Bourantas, KL; Briasoulis, E; Christou, L; Konstantinidou, P; Panteli, A; Tsiara, S	1
Alcala, A; Arias-Sampedro, J; Bosch, F; Fernandez, MN; Garcia-Conde, J; Guardia, R; Lopez-Lorenzo, JL; Manso, F; Martin, A; Montserrat, E; Odriozola, J; Oyarzabal, FJ; Prieto, E	1
Emilia, G; Ferrara, L; Gandini, G; Longo, G; Torelli, U	1
Antich Rojas, J; Balaguer, H; Cladera, A	1
Juliusson, G	1
Beal, CL; Byrd, JC; Chaffin, DJ; Vick, DJ	1
Azar, N; Binet, JL; Dighiero, G; Gabarre, J; Gonzalez, H; Leblond, V; Sutton, L; Vernant, JP	1
Bolam, S; Hamblin, TJ; Myint, H; Orchard, J; Oscier, DG	1
Hamblin, TJ; Myint, H; Orchard, JA; Oscier, DG	1
Kalaycio, M; Sen, K	1
Fiser, J; Jindra, P; Koza, V; Svojgrová, M; Vozobulová, V	1
Cerretti, R; Coluzzi, S; Foa, R; Giannarelli, D; Girelli, G; Mandelli, F; Mauro, FR	1
Rouger, P; Wautier, JL	1
Mounter, PJ; Proctor, SJ; Summerfield, GP; Taylor, PR	1
Ali Ege, M; Amadori, S; Caruso, R; D'Adamo, F; Girelli, G; Maurillo, L; Mauro, FR; Picardi, A; Tosti, S	1
Bastion, Y; Bryon, PA; Coiffier, B; Dumontet, C; Espinouse, D	1

Reviews

8 review(s) available for fludarabine and Anemia, Hemolytic, Autoimmune

Article	Year
How I treat autoimmune hemolytic anemia. Blood, 2017, 06-01, Volume: 129, Issue:22 Topics: Aged; Algorithms; Anemia, Hemolytic, Autoimmune; Coombs Test; Erythrocyte Transfusion; Female; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Rituximab; Serologic Tests; Splenectomy; Vidarabine	2017
Immune hemolytic anemia--selected topics. Hematology. American Society of Hematology. Education Program, 2009 Topics: Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Group Incompatibility; Cladribine; Combined Modality Therapy; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphocyte Subsets; Lymphoproliferative Disorders; Postoperative Complications; Rituximab; Splenectomy; Transfusion Reaction; Transplantation; Transplantation, Homologous; Venous Thromboembolism; Vidarabine	2009
How I manage cold agglutinin disease. British journal of haematology, 2011, Volume: 153, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Middle Aged; Rituximab; Vidarabine	2011
Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood reviews, 2012, Volume: 26, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Contraindications; Cryoglobulins; Drug Combinations; Erythrocyte Transfusion; Female; Humans; Middle Aged; Precision Medicine; Remission Induction; Rituximab; Vidarabine	2012
Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & lymphoma, 2007, Volume: 48, Issue:6 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Models, Biological; Vidarabine	2007
The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia. Seminars in hematology, 1996, Volume: 33, Issue:1 Suppl 1 Topics: Alkylation; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine	1996
Complications in the treatment of CLL with purine analogues. Hematology and cell therapy, 1997, Volume: 39 Suppl 1 Topics: Anemia, Hemolytic, Autoimmune; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Neutropenia; Purine Nucleosides; Vidarabine	1997
[Drug-induced hemolytic anemia]. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2001, Volume: 8, Issue:4 Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Cephalosporins; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Isoantibodies; Leukemia, Lymphocytic, Chronic, B-Cell; Methyldopa; Procainamide; Purpura, Thrombocytopenic; Quinine; Rho(D) Immune Globulin; Thrombocytopenia; Vidarabine	2001

Trials

3 trial(s) available for fludarabine and Anemia, Hemolytic, Autoimmune

Article	Year
Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood, 2020, 07-23, Volume: 136, Issue:4 Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies; Rituximab; Vidarabine	2020
Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia. Haematologica, 2013, Volume: 98, Issue:8 Topics: Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cohort Studies; Female; Humans; Immunotherapy; Incidence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Metabolic Clearance Rate; Middle Aged; Rituximab; Time Factors; Treatment Outcome; Vidarabine	2013
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease. Blood, 2010, Oct-28, Volume: 116, Issue:17 Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Middle Aged; Rituximab; Vidarabine	2010

Other Studies

37 other study(ies) available for fludarabine and Anemia, Hemolytic, Autoimmune

Article	Year
Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p). Annals of hematology, 2017, Volume: 96, Issue:9 Topics: Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Bridged Bicyclo Compounds, Heterocyclic; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Humans; In Situ Hybridization, Fluorescence; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Recurrence; Remission Induction; Rituximab; Sulfonamides; Vidarabine	2017
Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Resistance; Humans; Infant; Male; Red-Cell Aplasia, Pure; Sirolimus; Splenectomy; Treatment Outcome; Vidarabine	2014
Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. British journal of haematology, 2011, Volume: 154, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Berlin; beta-Lactams; Case-Control Studies; Ciprofloxacin; Diclofenac; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lorazepam; Male; Middle Aged; Odds Ratio; Piperacillin; Population Surveillance; Trimethoprim, Sulfamethoxazole Drug Combination; Vidarabine; Young Adult	2011
Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide. Annals of hematology, 2012, Volume: 91, Issue:5 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cryoglobulinemia; Cyclophosphamide; Female; Humans; Immunoglobulin M; Livedo Reticularis; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Rituximab; Vidarabine	2012
Fludarabine-induced hemolytic anemia: successful treatment by rituximab. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:1 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Blood Transfusion; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Rituximab; Treatment Outcome; Vidarabine	2004
Successful reduced-intensity allogeneic transplantation utilizing a fludarabine-based preparative regimen in a patient with chronic lymphocytic leukaemia and a history of fludarabine-associated autoimmune haemolytic anaemia. British journal of haematology, 2004, Volume: 126, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Transplantation Conditioning; Vidarabine	2004
Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. Clinical and laboratory haematology, 2006, Volume: 28, Issue:1 Topics: Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Hemolysis; Humans; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Rituximab; Vidarabine	2006
Fludarabine induced autoimmune haemolytic anaemia in a patient with chronic lymphocytic leukaemia. JPMA. The Journal of the Pakistan Medical Association, 2006, Volume: 56, Issue:1 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Vidarabine	2006
The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia. Haematologica, 2006, Volume: 91, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Case-Control Studies; Humans; Interferon-gamma; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Vidarabine	2006
Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia. Leukemia research, 2006, Volume: 30, Issue:12 Topics: Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Disease Progression; Humans; Infusions, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Prednisolone; Remission Induction; Risk Factors; Rituximab; Treatment Outcome; Vidarabine	2006
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? Leukemia research, 2007, Volume: 31, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hepatitis B; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Rituximab; Treatment Outcome; Vidarabine	2007
Graft failure and severe autoimmune haemolysis following fludarabine-based reduced-intensity matched unrelated donor bone marrow transplantation for severe aplastic anaemia: salvage by second transplant with conventional dose conditioning. Bone marrow transplantation, 2006, Volume: 38, Issue:4 Topics: Adolescent; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Female; Graft Rejection; Humans; Salvage Therapy; Tissue Donors; Vidarabine	2006
Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody). Leukemia, 2007, Volume: 21, Issue:3 Topics: Aged; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; CD52 Antigen; Chlorambucil; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Drug Resistance; Glycoproteins; Hemoglobins; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prednisone; Splenectomy; Treatment Outcome; Vidarabine; Vincristine	2007
Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. British journal of haematology, 2007, Volume: 136, Issue:6 Topics: Adolescent; Adult; Aged; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Glucocorticoids; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Prospective Studies; Red-Cell Aplasia, Pure; Retrospective Studies; Rituximab; Treatment Outcome; Vidarabine	2007
Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy. British journal of haematology, 2007, Volume: 139, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Rituximab; Vidarabine	2007
[Fludarabine and fatal hemolytic anemia]. Sangre, 1995, Volume: 40, Issue:4 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Vidarabine	1995
Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Aged; Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Purpura, Thrombocytopenic, Idiopathic; Recurrence; T-Lymphocyte Subsets; Vidarabine	1994
Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine. Leukemia & lymphoma, 1993, Volume: 11, Issue:1-2 Topics: Aged; Anemia, Hemolytic, Autoimmune; CD4-CD8 Ratio; Coombs Test; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Retrospective Studies; Vidarabine	1993
Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British journal of haematology, 1995, Volume: 91, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	1995
Fludarabine-related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. British journal of haematology, 1996, Volume: 92, Issue:3 Topics: Adult; Anemia, Hemolytic, Autoimmune; Fatal Outcome; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Vidarabine	1996
[Fludarabine and severe autoimmune hemolytic anemia: a new case]. La Revue de medecine interne, 1996, Volume: 17, Issue:8 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Male; Vidarabine	1996
Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia. Hematology and cell therapy, 1996, Volume: 38, Issue:4 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Fatal Outcome; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Vidarabine	1996
Cold agglutinin hemolysis responding to fludarabine therapy. American journal of hematology, 1996, Volume: 53, Issue:4 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antimetabolites; Cyclophosphamide; Drug Resistance; Humans; Male; Vidarabine	1996
Severe autoimmune hemolytic anemia following fludarabine therapy in a patient with chronic lymphocytic leukemia. American journal of hematology, 1997, Volume: 54, Issue:4 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Vidarabine	1997
Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience. Leukemia & lymphoma, 1996, Volume: 21, Issue:5-6 Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Cause of Death; Drug Evaluation; Fever; Graft vs Host Disease; Hematologic Diseases; Humans; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Life Tables; Remission Induction; Retrospective Studies; Salvage Therapy; Spain; Survival Analysis; Transfusion Reaction; Treatment Outcome; Vidarabine	1996
Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia. European journal of haematology, 1997, Volume: 59, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	1997
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia]. Sangre, 1997, Volume: 42, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine	1997
Mixed-type autoimmune hemolytic anemia following fludarabine treatment in a patient with chronic lymphocytic leukemia/small cell lymphoma. Vox sanguinis, 1998, Volume: 74, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Autoantibodies; Coombs Test; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Temperature; Vidarabine	1998
Severe autoimmune hemolytic anemia in eight patients treated with fludarabine. Hematology and cell therapy, 1998, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Dose-Response Relationship, Drug; Erythrocyte Transfusion; Hemolysis; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Survival Rate; Time Factors; Vidarabine	1998
In patients with lymphoid tumours recovering from the autoimmune complications of fludarabine, relapse may be triggered by conventional chemotherapy. British journal of haematology, 1998, Volume: 102, Issue:4 Topics: Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Vidarabine	1998
Fludarabine and hemolytic anemia in chronic lymphocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:9 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine	1998
Evan's syndrome precipitated by fludarabine therapy in a case of CLL. American journal of hematology, 1999, Volume: 61, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Female; Humans; Immune Tolerance; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Prednisone; Thrombocytopenia; Vidarabine	1999
Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: complete remission of lymphoma with control of autoimmune complications. Bone marrow transplantation, 1999, Volume: 24, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Combined Modality Therapy; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Transplantation, Autologous; Vidarabine	1999
Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood, 2000, May-01, Volume: 95, Issue:9 Topics: Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Multivariate Analysis; Prednisolone; Probability; Prognosis; Retrospective Studies; Risk Factors; Splenectomy; Survival Analysis; Time Factors; Vidarabine	2000
High-dose chlorambucil for the treatment of chronic lymphocytic leukaemia and low-grade non-Hodgkin's lymphoma. British journal of haematology, 2002, Volume: 116, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents, Alkylating; Chlorambucil; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Survival Rate; Vidarabine	2002
Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment. Annals of hematology, 1992, Volume: 65, Issue:5 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	1992
Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:2 Topics: Adult; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	1992